# TYENNE

NDC: 65219-596
Generic name: Tocilizumab-aazg
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20250901

FDA application: BLA761449

## Active ingredients

- TOCILIZUMAB: 162 mg/.9mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65219-596"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65219-596
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=87ac5047-4f2b-4571-a8a8-32e08865f379